CDHR4 (cadherin related family member 4) is a calcium-dependent cell adhesion molecule that functions through homophilic interactions to facilitate cell-cell connectivity and heterogeneous cell sorting [UniProt annotation]. As a member of the cadherin-related family, CDHR4 is involved in fundamental cell adhesion and plasma membrane localization processes. In cancer contexts, CDHR4 expression is downregulated in lung adenocarcinoma (LUAD) compared to normal tissue 1. CDHR4 has been identified as a component of a nine-gene prognostic risk score for clear cell renal cell carcinoma (ccRCC), where it contributes to distinguishing high-risk patients with shortened overall survival and advanced clinicopathological parameters; this risk score demonstrated independent predictive power and validation in external cohorts 2. Beyond cancer, CDHR4 genetic variants have been associated with post-traumatic stress disorder (PTSD) susceptibility in genome-wide association studies (GWAS), appearing among genes with repeated associations across multiple PTSD studies 3. Clinically, CDHR4 shows potential as a diagnostic and prognostic biomarker in multiple diseases, though mechanistic details connecting adhesion function to cancer progression and psychiatric disorder susceptibility require further investigation.